Facts about Lactobacillus rhamnosus (LGG®)
Identified as Lactobacillus rhamnosus
Originates from human intestinal microbiota and was discovered by Professors Gorbach and Goldin, giving name to the strain
LGG® is a registered trademark of Chr. Hansen A/S
Used worldwide since 1990 as an ingredient in food and dietary supplements, with no reported consumer illness or injury
Tested in clinical studies from newborn preterm infants to elderly populations in dosages up to at least 100 billion CFU/day, with no reported serious adverse events
The world’s best documented probiotic strain
Lactobacillus rhamnosus (LGG®) is the world’s best documented probiotic strain. It has been used in food and dietary supplements since 1990, has been described in more than 12001 scientific publications and studied in more than 3001 clinical studies.
The US Food and Drug Administration (FDA) has designated the LGG® strain as Generally Recognized As Safe (GRAS). In Europe, Lactobacillus rhamnosus has been granted Qualified Presumption of Safety (QPS) status since 2007 by the European Food Safety Authority (EFSA) – a status granted on species level.